ELV - CIK 0001156039
The table below shows Elevance Health, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $9.49B | $8.29B | $6.53B | $7.39B | $4.88B | $5.74B |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets | $63.00B |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $58.94B |
| $60.03B |
| $55.62B |
| $51.12B |
| $45.75B |
| Property, plant & equipment | $4.68B | $4.65B | $4.36B | $4.32B | $3.92B | $3.48B |
| Goodwill | $28.34B | $28.28B | $25.32B | $24.38B | $24.23B | $21.69B |
| Total assets | $121.49B | $116.89B | $108.93B | $102.77B | $97.46B | $86.61B |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $41.03B | $40.58B | $41.79B | $39.70B | $34.88B | $29.45B |
| Long-term debt | $30.80B | $29.22B | $23.25B | $22.35B | $21.16B | $19.34B |
| Total liabilities | $77.47B | $75.46B | $69.52B | $66.38B | $61.33B | $53.42B |
| Retained earnings | $35.39B | $33.55B | $31.75B | $29.72B | $27.09B | $23.80B |
| Total equity | $43.88B | $41.31B | $39.31B | $36.31B | $36.06B | $33.20B |